Owkin Enters Collaboration Agreement With MSD To Develop AI-Powered Diagnostics for Cancer

0
75
Owkin announced that it has entered into a collaboration agreement with MSD, the tradename of Merck & Co Inc., Rahway NJ USA to develop and commercialize AI-powered digital pathology diagnostics for the European Union market.
[Owkin]
Press Release